Activator Protein-1 and Epidermal Growth Factor Receptor Interplay : In Vivo & In Vitro Studies

Critical cellular decisions such as should the cell proliferate, migrate or differentiate, are regulated by stimulatory signals from the extracellular environment, like growth factors. These signals are transformed to cellular responses through their binding to specific receptors present at the surface of the recipient cell. The epidermal growth factor receptor (EGF-R/ErbB) pathway plays key roles in governing these signals to intracellular events and cell-to-cell communication. The EGF-R forms a signaling network that participates in the specification of cell fate and coordinates cell proliferation. Ligand binding triggers receptor dimerization leading to the recruitment of kinases and adaptor proteins. This step simultaneously initiates multiple signal transduction pathways, which result in activation of transcription factors and other target proteins, leading to cellular alterations. It is known that mutations of EGF-R or in the components of these pathways, such as Ras and Raf, are commonly involved in human cancer. The four best characterized signaling pathways induced by EGF-R are the mitogen-activated protein kinase cascades (MAPKs), the lipid kinase phosphatidylinositol 3 kinase (PI3K), a group of transcription factors called Signal Transducers and Activator of Transcription (STAT), and the phospholipase Cγ; (PLCγ) pathways. The activation of each cascade culminates in kinase translocation to the nucleus to stimulate various transcription factors including activator protein 1 (AP-1). AP-1 family proteins are basic leucine zipper (bZIP) transcription factors that are implicated in the regulation of a variety of cellular processes (proliferation and survival, growth, differentiation, apoptosis, cell migration, transformation). Therefore, the regulation of AP-1 activity is critical for the decision of cell fate and their deregulated expression is widely associated with many types of cancers, such as breast and prostate cancers. The aims of this study were to characterize the roles of EGF-R signaling during normal development and malignant growth in vitro and in vivo using different cell lines and tissue samples. We show here that EGF-R regulates cell proliferation but is also required for regulation of AP-1 target gene expression in fibroblasts in a MAP-kinase mediated manner. Furthermore, EGF-R signaling is essential for enterocyte proliferation and migration during intestinal maturation. EGF-R signaling network, especially PI3-K-Akt pathway mediated AP-1 activity is involved in cellular survival in response to ionizing radiation. Taken together, these results elucidate the connection of EGF-R and AP-1 in various cellular contexts and show their importance in the regulation of cellular behaviour presenting new treatment cues for intestinal perforations and cancer therapy.

Molecular classification of familial colorectal and endometrial carcinoma

Hereditary nonpolyposis colorectal cancer (HNPCC) is the most common known clearly hereditary cause of colorectal and endometrial cancer (CRC and EC). Dominantly inherited mutations in one of the known mismatch repair (MMR) genes predispose to HNPCC. Defective MMR leads to an accumulation of mutations especially in repeat tracts, presenting microsatellite instability. HNPCC is clinically a very heterogeneous disease. The age at onset varies and the target tissue may vary. In addition, families that fulfill the diagnostic criteria for HNPCC but fail to show any predisposing mutation in MMR genes exist. Our aim was to evaluate the genetic background of familial CRC and EC. We performed comprehensive molecular and DNA copy number analyses of CRCs fulfilling the diagnostic criteria for HNPCC. We studied the role of five pathways (MMR, Wnt, p53, CIN, PI3K/AKT) and divided the tumors into two groups, one with MMR gene germline mutations and the other without. We observed that MMR proficient familial CRC consist of two molecularly distinct groups that differ from MMR deficient tumors. Group A shows paucity of common molecular and chromosomal alterations characteristic of colorectal carcinogenesis. Group B shows molecular features similar to classical microsatellite stable tumors with gross chromosomal alterations. Our finding of a unique tumor profile in group A suggests the involvement of novel predisposing genes and pathways in colorectal cancer cohorts not linked to MMR gene defects. We investigated the genetic background of familial ECs. Among 22 families with clustering of EC, two (9%) were due to MMR gene germline mutations. The remaining familial site-specific ECs are largely comparable with HNPCC associated ECs, the main difference between these groups being MMR proficiency vs. deficiency. We studied the role of PI3K/AKT pathway in familial ECs as well and observed that PIK3CA amplifications are characteristic of familial site-specific EC without MMR gene germline mutations. Most of the high-level amplifications occurred in tumors with stable microsatellites, suggesting that these tumors are more likely associated with chromosomal rather than microsatellite instability and MMR defect. The existence of site-specific endometrial carcinoma as a separate entity remains equivocal until predisposing genes are identified. It is possible that no single highly penetrant gene for this proposed syndrome exists, it may, for example be due to a combination of multiple low penetrance genes. Despite advances in deciphering the molecular genetic background of HNPCC, it is poorly understood why certain organs are more susceptible than others to cancer development. We found that important determinants of the HNPCC tumor spectrum are, in addition to different predisposing germline mutations, organ specific target genes and different instability profiles, loss of heterozygosity at MLH1 locus, and MLH1 promoter methylation. This study provided more precise molecular classification of families with CRC and EC. Our observations on familial CRC and EC are likely to have broader significance that extends to sporadic CRC and EC as well.

The mast cell as a regulator of atherosclerotic plaque stability

Atherosclerosis is an inflammatory disease progressing over years via the accumulation of cholesterol in arterial intima with subsequent formation of atherosclerotic plaques. The stability of a plaque is determined by the size of its cholesterol-rich necrotic lipid core and the thickness of the fibrous cap covering it. The strength and thickness of the cap are maintained by smooth muscle cells and the extracellular matrix produced by them. A plaque with a large lipid core and a thin cap is vulnerable to rupture that may lead to acute atherothrombotic events, such as myocardial infarction and stroke. In addition, endothelial erosion, possibly induced by apoptosis of endothelial cells, may lead to such clinical events. One of the major causes of plaque destabilization is inflammation induced by accumulated and modified lipoproteins, and exacerbated by local aberrant shear stress conditions. Macrophages, T-lymphocytes and mast cells infiltrate particularly into the plaque’s shoulder regions prone to atherothrombotic events, and they are present at the actual sites of plaque rupture and erosion. Two major mechanisms of plaque destabilization induced by inflammation are extracellular matrix remodeling and apoptosis. Mast cells are bone marrow-derived inflammatory cells that as progenitors upon chemotactic stimuli infiltrate the target tissues, such as the arterial wall, differentiate in the target tissues and mediate their effects via the release of various mediators, typically in a process called degranulation. The released preformed mast cell granules contain proteases such as tryptase, chymase and cathepsin G bound to heparin and chondroitin sulfate proteoglycans. In addition, various soluble mediators such as histamine and TNF-alpha are released. Mast cells also synthesize many mediators such as cytokines and lipid mediators upon activation. Mast cells are capable of increasing the level of LDL cholesterol in the arterial intima by increasing accumulation and retention of LDL and by decreasing removal of cholesterol by HDL in vitro. In addition, by secreting proinflammatory mediators and proteases, mast cells may induce plaque destabilization by inducing apoptosis of smooth muscle and endothelial cells. Also in vivo data from apoE-/- and ldlr-/- mice suggest a role for mast cells in the progression of atherosclerosis. Furthermore, mast cell-deficient mice have become powerful tools to study the effects of mast cells in vivo. In this study, evidence suggesting a role for mast cells in the regulation of plaque stability is presented. In a mouse model genetically susceptible to atherosclerosis, mast cell deficiency (ldlr-/-/KitW-sh/W-sh mice) was associated with a less atherogenic lipid profile, a decreased level of lipid accumulation in the aortic arterial wall and a decreased level of vascular inflammation as compared to mast-cell competent littermates. In vitro, mast cell chymase-induced smooth muscle cell apoptosis was mediated by inhibition of NF-kappaB activity, followed by downregulation of bcl-2, release of cytochrome c, and activation of caspase-8, -9 and -3. Mast cell-induced endothelial cell apoptosis was mediated by chymase and TNF-alpha, and involved chymase-mediated degradation of fibronectin and vitronectin, and inactivation of FAK- and Akt-mediated survival signaling. Subsequently, mast cells induced inhibition of NF-kappaB activity and activation of caspase-8 and -9. In addition, possible mast cell protease-mediated mechanisms of endothelial erosion may include degradation of fibronectin and VE-cadherin. Thus, the present results suggest a role for mast cells in destabilization of atherosclerotic plaques.

Structure and function of GDNF receptor alpha splice variants

The growth factors of the glial cell line-derived neurotrophic factor (GDNF) family consisting of GDNF, neurturin (NRTN), artemin (ARTN) and persephin (PSPN), are involved in the development, differentiation and maintenance of many types of neurons. They also have important functions outside the nervous system in the development of kidney, testis and thyroid gland. Each of these GFLs preferentially binds to one of the glycosylphosphatidylinositol (GPI)-anchored GDNF family receptors α (GFRα). GDNF binds to GFRα1, NRTN to GFRα2, ARTN to GFRα3 and PSPN to GFRα4. The GFLs in the complex with their cognate GFRα receptors all bind to and signal through the receptor tyrosine kinase RET. Alternative splicing of the mouse GFRα4 gene yields three splice isoforms. These had been described as putative GPI-anchored, transmembrane and soluble forms. My goal was to characterise the function of the different forms of mouse GFRα4. I firstly found that the putative GPI-anchored GFRα4 (GFRα4-GPI) is glycosylated, membrane-bound, GPI-anchored and interacts with PSPN and RET. We also showed that mouse GFRα4-GPI mediates PSPN-induced phosphorylation of RET, promotes PSPN-dependent neuronal differentiation of the rat pheochromocytoma cell line PC6-3 and PSPN-dependent survival of cerebellar granule neurons (CGN). However, although this receptor can mediate PSPN-signalling and activate RET, GFRα4-GPI does not recruit RET into lipid rafts. The recruitment of RET into lipid rafts has previously been thought to be a crucial event for GDNF- and GFL-mediated signalling via RET. I secondly demonstrated that the putative transmembrane GFRα4 (GFRα4-TM) is indeed a real transmembrane GFRα4 protein. Although it has a weak binding capacity for PSPN, it can not mediate PSPN-dependent phosphorylation of RET, neuronal differentiation or survival. These data show that GFRα4-TM is inactive as a receptor for PSPN. Surprisingly, GFRα4-TM can negatively regulate PSPN-mediated signalling via GFRα4-GPI. GFRα4-TM interacts with GFRα4-GPI and blocks PSPN-induced phosphorylation of RET, neuronal differentiation as well as survival. Taken together, our data show that GFRα4-TM may act as a dominant negative inhibitor of PSPN-mediated signaling. The most exciting part of my work was the finding that the putative soluble GFRα4 (GFRα4-sol) can form homodimers and function as an agonist of the RET receptor. In the absence of PSPN, GFRα4-sol can promote the phosphorylation of RET, trigger the activation of the PI-3K/AKT pathway, induce neuronal differentiation and support the survival of CGN. Our findings are in line with a recent publication showing the GFRα4-sol might contribute to the inherited cancer syndrome multiple endocrine neoplasia type 2. Our data provide an explanation to how GFRα4-sol may cause or modify the disease. Mammalian GFRα4 receptors all lack the first Cys-rich domain which is present in other GFRα receptors. In the final part of my work I have studied the function of this particular domain. I created a truncated GFRα1 construct lacking the first Cys-rich domain. Using binding assays in both cellular and cell-free systems, phosphorylation assays with RET, as well as neurite outgrowth assays, we found that the first Cys-rich domain contributes to an optimal function of GFRα1, by stabilizing the interaction between GDNF and GFRα1.

Immune mechanisms in atherosclerosis; Focus on the role of the complement system

Atherosclerosis is an inflammatory disease characterized by accumulation of lipids in the inner layer of the arterial wall. During atherogenesis, various structures that are recognized as non-self by the immune system, such as modified lipoproteins, are deposited in the arterial wall. Accordingly, atherosclerotic lesions and blood of humans and animals with atherosclerotic lesions show signs of activation of both innate and adaptive immune responses. Although immune attack is initially a self-protective reaction, which is meant to destroy or remove harmful agents, a chronic inflammatory state in the arterial wall accelerates atherosclerosis. Indeed, various modulations of the immune system of atherosclerosis-prone animals have provided us with convincing evidence that immunological mechanisms play an important role in the pathogenesis of atherosclerosis. This thesis focuses on the role of complement system, a player of the innate immunity, in atherosclerosis. Complement activation via any of the three different pathways (classical, alternative, lectin) proceeds as a self-amplifying cascade, which leads to the generation of opsonins, anaphylatoxins C3a and C5a, and terminal membrane-attack complex (MAC, C5b-9), all of which regulate the inflammatory response and act in concert to destroy their target structures. To prevent uncontrolled complement activation or its attack against normal host cells, complement needs to be under strict control by regulatory proteins. The complement system has been shown to be activated in atherosclerotic lesions, modified lipoproteins and immune complexes containing oxLDL, for instance, being its activators. First, we investigated the presence and role of complement regulators in human atherosclerotic lesions. We found that inhibitors of the classical and alternative pathways, C4b-binding protein and factor H, respectively, were present in atherosclerotic lesions, where they localized in the superficial proteoglycan-rich layer. In addition, both inhibitors were found to bind to arterial proteoglycans in vitro. Immunohistochemical stainings revealed that, in the superficial layer of the intima, complement activation had been limited to the C3 level, whereas in the deeper intimal layers, complement activation had proceeded to the terminal C5b-9 level. We were also able to show that arterial proteoglycans inhibit complement activation in vitro. These findings suggested to us that the proteoglycan-rich layer of the arterial intima contains matrix-bound complement inhibitors and forms a protective zone, in which complement activation is restricted to the C3 level. Thus, complement activation is regulated in atherosclerotic lesions, and the extracellular matrix is involved in this process. Next, we studied whether the receptors for the two complement derived effectors, anaphylatoxins C3a and C5a, are expressed in human coronary atherosclerotic lesions. Our results of immunohistochemistry and RT-PCR analysis showed that, in contrast to normal intima, C3aR and C5aR were highly expressed in atherosclerotic lesions. In atherosclerotic plaques, the principal cells expressing both C3aR and C5aR were macrophages. Moreover, T cells expressed C5aR, and a small fraction of them also expressed C3aR, mast cells expressed C5aR, whereas endothelial cells and subendothelial smooth muscle cells expressed both C3aR and C5aR. These results suggested that intimal cells can respond to and become activated by complement-derived anaphylatoxins. Finally, we wanted to learn, whether oxLDL-IgG immune complexes, activators of the classical complement pathway, could have direct cellular effects in atherogenesis. Thus, we tested whether oxLDL-IgG immune complexes affect the survival of human monocytes, the precursors of macrophages, which are the most abundant inflammatory cell type in atherosclerotic lesions. We found that OxLDL-IgG immune complexes, in addition to transforming monocytes into foam cells, promoted their survival by decreasing their spontaneous apoptosis. This effect was mediated by cross-linking Fc receptors with ensuing activation of Akt-dependent survival signaling. Our finding revealed a novel mechanism by which oxLDL-IgG immune complexes can directly affect the accumulation of monocyte-macrophages in human atherosclerotic lesions and thus play a role in atherogenesis.

Diabetic cardiomyopathy and post-infarct ventricular remodelling : Effects of levosimendan in a rodent model of type II diabetes

Type 2 diabetes is a risk factor for the development of cardiovascular disease. Recently, the term diabetic cardiomyopathy has been proposed to describe the changes in the heart that occur in response to chronic hyperglycemia and insulin resistance. Ventricular remodelling in diabetic cardiomyopathy includes left ventricular hypertrophy, increased interstitial fibrosis, apoptosis and diastolic dysfunction. Mechanisms behind these changes are increased oxidative stress and renin-angiotensin system activation. The diabetic Goto-Kakizaki rat is a non-obese model of type 2 diabetes that exhibits defective insulin signalling. Recently two interconnected stress response pathways have been discovered that link insulin signalling, longevity, apoptosis and cardiomyocyte hypertrophy. The insulin-receptor PI3K/Ak pathway inhibits proapoptotic FOXO3a in response to insulin signalling and the nuclear Sirt1 deacetylase inhibits proapoptotic p53 and modulates FOXO3a in favour of survival and growth. --- Levosimendan is a calcium sensitizing agent used for the management of acute decompensated heart failure. Levosimendan acts as a positive inotrope by sensitizing cardiac troponin C to calcium and exerts vasodilation by opening mitochondrial and sarcolemmal ATP-sensitive potassium channels. Levosimendan has been described to have beneficial effects in ventricular remodelling after myocardial infarction. The aims of the study were to characterize whether diabetic cardiomyopathy associates with cardiac dysfunction, cardiomyocyte apoptosis, hypertrophy and fibrosis in spontaneously diabetic Goto-Kakizaki (GK) rats, which were used to model type 2 diabetes. Protein expression and activation of the Akt FOXO3a and Sirt1 p53 pathways were examined in the development of ventricular remodelling in GK rats with and without myocardial infarction (MI). The third and fourth studies examined the effects of levosimendan on ventricular remodelling and gene expression in post-MI GK rats. The results demonstrated that diabetic GK rats develop both modest hypertension and features similar to diabetic cardiomyopathy including cardiac dysfunction, LV hypertrophy and fibrosis and increased apoptotic signalling. MI induced a sustained increase in cardiomyocyte apoptosis in GK rats together with aggravated LV hypertrophy and fibrosis. The GK rat myocardium exhibited decreased Akt- FOXO3a phosphorylation and increased nuclear translocation of FOXO3a and overproduction of the Sirt1 protein. Treatment with levosimendan decreased cardiomyocyte apoptosis, senescence and LV hypertrophy and altered the gene expression profile in GK rat myocardium. The findings indicate that impaired cardioprotection via Akt FOXO3a and p38 MAPK is associated with increased apoptosis, whereas Sirt1 functions in counteracting apoptosis and the development of LV hypertrophy in the GK rat myocardium. Overall, levosimendan treatment protects against post-MI ventricular remodelling and alters the gene expression profile in the GK rat myocardium.

Sokeri, kauppa ja kehitys : kehityspoliittinen johdonmukaisuus Euroopan unionin interventiossa Afrikan, Karibian ja Tyynenmeren valtioihin

Tutkielmassa tarkastelen Euroopan unionin (EU) kehityspoliittisen johdonmukaisuuden periaatetta, eli kehitysyhteistyön tavoitteiden huomioonottamista muilla politiikanaloilla. Tutkimuskohteeni on EU:n maatalous- ja kauppapoliittisten toimenpiteiden ja EU:n kehityspolitiikan yhteisvaikutus neljässä Lomén sopimuksen sokeripöytäkirjaan kuuluneessa Afrikan, Karibian ja Tyynenmeren (AKT) valtiossa: Fidzissä, Guyanassa, Malawissa ja Tansaniassa. Sokeripolitiikka avaa politiikkajohdonmukaisuuteen mielenkiintoisen näkökulman, koska siinä yhdistyvät EU:n kauppa- ja maatalouspoliittiset intressit ja koska se on ollut tärkeässä osassa EU:n ja AKT-maiden välisissä suhteissa. Sokeripöytäkirja oli keskeinen osa EU:n etuuskohtelujärjestelmää, joka piti Afrikan, Karibian ja Tyynenmeren valtiot unionin etuoikeutetuimpana kumppanimaaryhmänä. 1990-luvulla alkaneet kehityspolitiikan alueellisten ja sisällöllisten painotusten muutokset johtivat lopulta myös sokeripöytäkirjan purkamiseen. EU:n sokeripolitiikan uudistukset ovat vaikuttaneet tapausmaihin eri tavalla. EU:n aiemmasta sokeripolitiikasta hyötyneet sokeripöytäkirjamaat joutuvat jatkossa avoimeen kilpailuun toistensa ja muiden vähiten kehittyneiden maiden ja AKT-maiden kanssa. Fidzille ja Guyanalle uusi tilanne voi koitua kohtalokkaaksi, mutta Malawille ja Tansanialle markkinoillepääsyn helpottuminen avaa uusia mahdollisuuksia. EU:n sokeripolitiikasta ja kehitysyhteistyöstä muodostuva interventio tapausmaissa osoittaa, että EU on ottanut huomioon sen sokeripolitiikan aiheuttamat vaikutukset kaikissa tapausmaissa. Intervention perusteella kehitysyhteistyön instrumentteja voidaan käyttää kumoamaan muiden EU:ssa vahvempien politiikka-alojen kielteisiä vaikutuksia ja auttamaan kehitysmaita sopeutumaan uusiin olosuhteisiin. Interventio näyttäisi EU:n omaksuneen enemmän tai vähemmän johdonmukaisen lähestymistavan tapausmaita kohtaan. Lähempi tarkastelu kuitenkin osoittaa intervention edustavan johdonmukaisuutta ennemmin kauppapoliittisten tavoitteiden kuin kehitysyhteistyön tavoitteiden näkökulmasta. Päätelmieni mukaan kehityspoliittista johdonmukaisuutta voidaan tulkita osana EU:n laajempia kauppapoliittisia pyrkimyksiä. Määrittelemällä tiettyjä politiikkoja kehityspoliittisen johdonmukaisuuden periaatteen mukaiseksi, EU on voinut hakea oikeutusta pääasiassa vapaakauppaa tukeville aloitteilleen. Tutkielmassa osoitan, kuinka politiikkojen välistä kehitystä tukevaa johdonmukaisuutta voidaan arvioida ottamalla samaan aikaan huomioon sekä kehitysyhteistyön että muiden politiikanalojen vaikutukset yhden intervention osina. Valitsemani näkökulman perusteella kehityspoliittisen johdonmukaisuuden edistämisessä voitaisiin antaa enemmän vastuuta kehitysyhteistyölle ja kehityspolitiikalle.

Oriin seminaaliplasman matriksimetalloproteinaasit

Siirto- ja pakastesiemennysten lisääntyessä tammojen hedelmällisyystulosten parantuminen on hevoskasvatuksen taloudellisuuden kannalta merkittävää. Oriitten spermoissa on eroja sekä siirto- että pakastekestävyydessä. Pelkällä orivalinnalla ei voida kuitenkaan vaikuttaa hedelmällisyystuloksiin, sillä yleensä valinta painottuu suorituskykyyn. Siittiöiden lisäksi seminaaliplasmalla on havaittu vaikutuksia siirto- ja pakastuskestävyyteen. Seminaaliplasma koostuu useista erilaisista biologisista komponenteista, joista matriksimetalloproteinaasit (MMP) ovat yksi. Ne ovat proteiiniperhe, johon kuluu useita jäseniä. MMP:t kykenevät hajottamaan muun muassa solun ulkoisia tukirakenteita sekä tyvikalvoa erilaisissa fysiologisissa ja patologisissa tiloissa. Matriksimetalloproteinaaseja on löydetty useista kudoksista ja myös seminaaliplasmasta. Työn tutkimusosuudessa haluttiin selvittää MMP-pitoisuuksia, niiden vaihteluita oriitten välillä ja mahdollisia vaikutuksia hedelmällisyystuloksiin. Seminaaliplasmanäytteitä tutkittiin yhteensä 43 oriista. Näytteet oli kerätty astutuskaudella 2006 erirotuisilta ja -ikäisiltä hevosilta sekä kahdelta ponilta. Keräysvaiheessa näytteet jaoteltiin 1-4 eri fraktioon. Jokaisesta näytteestä tutkittiin MMP:t zymografian avulla. Seminaaliplasmanäytteiden lisäksi oriilta kerättiin hedelmällisyystietoja siittoloista sekä Suomen raviurheilun ja hevoskasvatuksen keskusjärjestöltä (Suomen Hippos ry). Kaikki tulokset taulukoitiin ja laskettiin aktiiviselle (akt-MMP-2) ja pro-MMP-2:lle sekä kokonais-MMP-9:lle (tot-MMP-9) siittiörikkaassa (SR) ja siittiököyhässä fraktiossa (SK) sekä kokonaisejakulaatissa (KE): keskiarvot, keskihajonnat, mediaanit sekä maksimi- ja minimiarvot. Spearmanin järjestyskorrelaatiokertoimet laskettiin tammojen ensimmäiseen kiimaan tiinehtymisen ja eri MMP-pitoisuuksien välille SR:ssa ja KE:ssa. Oriilla oli havaittavia pitoisuuksia pro- ja akt-MMP-2:ta sekä tot-MMP-9:ää. MMP-pitoisuudet olivat suurimmat SR:ssa. Suurimpia olivat pro-MMP-2:n pitoisuudet ja orikohtaiset erot olivat siinä pieniä. Saadut tulokset vastasivat odotuksia, sillä miesten seminaaliplasmatutkimusten tulokset ovat samansuuntaisia. Eri MMP-pitoisuuksilla ei havaittu korrelaatiota tammojen tiinehtymiseen kanssa. Aineiston pienen koon takia sattumalla voi olla suuri vaikutus tuloksiin. Myös keräysvuodenaika ja yksilön ejakulaation koostumusvaihtelut saattavat vaikuttaa seminaaliplasman MMP-pitoisuuksiin, sillä sen useissa ominaisuuksissa tapahtuu muutoksia näiden muuttujien mukaan. Tulokset ovat suuntaa antavia ja toimivat apuna jatkotutkimuksia suunniteltaessa.

Ihmisoikeusperusteista ulkopolitiikkaa : kansalaisjärjestöjen vaikutus Suomen suhtautumiseen Etelä-Afrikan järjestelmälliseen rotuerotteluun vuosina 1985-1987.

Apartheid eli rotuerottelupolitiikka sai virallisen statuksen Etelä-Afrikassa vuonna 1948. Merkittävimpänä Etelä-Afrikan sisäisenä apartheidpolitiikkaa vastustavana järjestönä profiloitui African National Congress. ANC:n ja kommunistien yhteydet pitivät johtavat länsivallat ja Etelä-Afrikan tärkeimmät kauppakumppanit Yhdysvallat ja Iso-Britannian puuttumatta maan sisäisiin asioihin. 1960-luvulla ANC:n toiminta meni maan alle ja kansainvälinen antiapartheidliikehdintä sai paljon nostetta.Suomessa Etelä-Afrikan apartheidpolitiikan vastustus tuli osaksi 60-luvun vasemmistopainotteisten opiskelijaliikkeiden retoriikkaa, mutta 1980-luvulle tultaessa antiapartheid-liikkeen suomalainen haara koostui sekä vasemmistolaisista että oikeistolaisista jäsenistä. Myös kirkon merkittävä rooli tässä ulkopoliittisessa kysymyksessä on merkittävä. Tutkin kansalaisjärjestöjen vaikutusmahdollisuuksia ulkopolitiikkaan ja yleensäkin Suomen ulkopolitiikassa tapahtunutta murrosta realismista ihmisoikeudelliseen lähestymistapaan. Olen tullut johtopäätökseen, että tarkastelemani ajanjakson maailmanpoliittinen tilanne ei vaikuttanut totutun lailla Suomen ulkopoliittiseen päätöksentekoon: käsitteenä suomettumattomuus kuvaa tilannetta hyvin. Apartheidkysymys ei ollut taloudellisesti merkittävä, sillä kauppa Suomen ja Etelä-Afrikan välillä oli todella pientä. Aikanaan sitä kuitenkin käytettiin perusteluna suhteiden jatkamiselle ja tutkijalle tulikin käsitys, että pelaajina tässä olivat lähinnä antiapartheid-liike, kirkko sekä ay-liike yhtenä rintamana elinkeinoelämää vastaan. Elinkeinoelämän edustajana tässä nähtiin reaalipolitiikkaan tukeutunut ulkoministeriö. Suomen ihmisoikeuspolitiikka oli näkymätöntä verrattuna muihin Pohjoismaihin ja se kulki lähes aina YK:n kautta universaalisuusperiaatteeseen ja puolueettomuuspolitiikkaan vedoten. Monenkeskisessä maailmassa poliittinen mahdollisuusrakenne muuttui ja kolmannen sektorin toimijat saivat ulkopoliittista painoarvoa. Suomi kielsi Etelä-Afrikan kaupan vuonna 1987 kansalaisyhteiskunnasta kaikuneiden vaatimusten takia. Suurimpina toimijoina olivat Auto- ja Kuljetusalan Työntekijäliitto AKT, Eristetään Etelä-Afrikka kampanja EELAK ja Suomen luterilainen kirkko. AKT:n tavarankuljetusboikotti 1985 oli merkittävin konkreettinen toimenpide, jolla hallitusta painostettiin lopettamaan Etelä-Afrikan kauppa. Kyseessä oli ensimmäinen kerta, kun kansalaisjärjestöillä oli merkittävää vaikutusta Suomen ulkopolitiikkaan ja ainoa kerta, kun Suomi on asettanut jonkun maan talousboikottiin ilman YK:n turvallisuusneuvoston yksimielistä päätöstä. Tutkimus koostuu kansalaisjärjestöaktiivien haastatteluista ja aikaisemman tutkimuskirjallisuuden sekä viranomaislähteiden analyysistä. Ihmisoikeuksien ja yleisen mielipiteen vaikutus ulkopolitiikan hoitoon kylmän sodan liennytysvaiheessa tulee ilmi myös kansainvälisten suhteiden turbulenssi-teoriaa soveltamalla. Suomalainen kehitys antiapartheidliikehdinnässä kulki Pohjoismaiden perässä.

Functional regulation of the Neurofibromatosis 2 tumor suppressor merlin

Neurofibromatosis 2 (NF2) is an autosomal dominant disorder manifested by the formation of multiple benign tumors of the nervous system. Affected individuals typically develop bilateral vestibular schwannomas which lead to deafness and balance disorders. The syndrome is caused by inactivation of the NF2 tumor suppressor gene, and mutation or loss of the NF2 product, merlin, is sufficient for tumorigenesis in both hereditary and sporadic NF2-associated tumors. Merlin belongs to the band 4.1 superfamily of cytoskeletal proteins, which also contain the related ezrin, radixin, and moesin (ERM) proteins. The ERM members provide a link between the cell cytoskeleton and membrane by connecting membrane-associated proteins to actin filaments. By stabilizing complexes in the cell cortex, the ERMs modulate morphology, growth, and migration of cells. Despite their structural homology, overlapping subcellular distribution, direct molecular association, and partial overlap of molecular interactions, merlin and ezrin exert opposite effects on cell proliferation. Merlin suppresses cell proliferation, whereas ezrin expression is linked to oncogenic activity. We hypothesized that the regions which differ between the proteins might explain merlin s specificity as a tumor suppressor. We therefore analyzed the regions, which are most diverse between merlin and ezrin; the N-terminal tail and the C-terminus. To determine the properties of the C-terminal region, we studied the two most predominant merlin isoforms together with truncation variants similar to those found in patients. We also focused on the evolutionally conserved C-terminal residues, E545-E547, that harbor disease causing mutations in its corresponding DNA sequence. In addition to inhibiting cell proliferation, merlin regulates cytoskeletal organization. The morphogenic properties of merlin may play a role in tumor suppression, since patient-derived tumor cells demonstrate cytoskeletal abnormalities. We analyzed the mechanisms of merlin-induced extension formation and determined that the C-terminal region of amino acids 538-568 is particularly important for the morphogenic activity. We also characterized the role of C-terminal merlin residues in the regulation of proliferation, phosphorylation, and intramolecular associations. In contrast to previous reports, we demonstrated that both merlin isoforms are able to suppress cell proliferation, whereas C-terminally mutated merlin constructs showed reduced growth inhibition. Phosphorylation serves as a mechanism to regulate the tumor suppressive activity of merlin. The C-terminal serine 518 is phosphorylated in response to both p21-activated kinase (PAK) and protein kinase A (PKA), which inactivates the growth inhibitory function of merlin. However, at least three differentially phosphorylated forms of the protein exist. In this study we demonstrated that also the N-terminus of merlin is phosphorylated by AGC kinases, and that both PKA and Akt phosphorylate merlin at serine 10 (S10). We evaluated the impact of this N-terminal tail phosphorylation, and showed that the phosphorylation state of S10 is an important regulator of merlin s ability to modulate cytoskeletal organization but also regulates the stability of the protein. In summary, this study describes the functional effect of merlin specific regions. We demonstrate that both S10 in the N-terminal tail and residues E545-E547 in the C-terminus are essential for merlin activity and function.